Skip to main content
Top
Published in: Breast Cancer Research 1/2017

Open Access 01-12-2017 | Erratum

Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer

Authors: Zhi Hu, Jian-Hua Mao, Christina Curtis, Ge Huang, Shenda Gu, Laura Heiser, Marc E. Lenburg, James E. Korkola, Nora Bayani, Shamith Samarajiwa, Jose A. Seoane, Mark A. Dane, Amanda Esch, Heidi S. Feiler, Nicholas J. Wang, Mary Ann Hardwicke, Sylvie Laquerre, Jeff Jackson, Kenneth W. Wood, Barbara Weber, Paul T. Spellman, Samuel Aparicio, Richard Wooster, Carlos Caldas, Joe W. Gray

Published in: Breast Cancer Research | Issue 1/2017

Login to get access

Excerpt

In the version of this article that was published on PubMed [1] the author’s name “Mark A. Dane” was formatted incorrectly in the XML mark up and therefore appeared incorrectly on PubMed. In the XML mark up, the middle initial “A” was added as a Particle when it should have been included as a Given Name. Due to this error, the author’s name was incorrectly formatted in PubMed as “A Dane M” and not as “Dane MA”. The author’s name is correct on the BioMed Central website. The author's name in the XML of the original article [1] has been updated accordingly. …
Literature
Metadata
Title
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer
Authors
Zhi Hu
Jian-Hua Mao
Christina Curtis
Ge Huang
Shenda Gu
Laura Heiser
Marc E. Lenburg
James E. Korkola
Nora Bayani
Shamith Samarajiwa
Jose A. Seoane
Mark A. Dane
Amanda Esch
Heidi S. Feiler
Nicholas J. Wang
Mary Ann Hardwicke
Sylvie Laquerre
Jeff Jackson
Kenneth W. Wood
Barbara Weber
Paul T. Spellman
Samuel Aparicio
Richard Wooster
Carlos Caldas
Joe W. Gray
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2017
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-017-0809-6

Other articles of this Issue 1/2017

Breast Cancer Research 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine